A. Domnich

mRNA-based seasonal influenza vaccines: an overview of immunogenicity, efficacy, and safety

Available seasonal influenza vaccines, most of which are still produced in eggs, have several limitations. Messenger RNA (mRNA) technology has emerged as a transformative approach capable of overcoming some of these shortcomings. This overview synthesizes clinical trials evaluating the immunogenicity, efficacy, and saf...